Liang Zhou[Author] - Search Results

Year	Number of Results
2002	5
2003	4
2004	18
2005	17
2006	23
2007	21
2008	26
2009	43
2010	37
2011	39
2012	74
2013	79
2014	77
2015	93
2016	80
2017	99
2018	107
2019	132
2020	157
2021	194
2022	205
2023	172
2024	64

1

Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy.

Wang L, Cai J, Zhao X, Ma L, Zeng P, Zhou L, Liu Y, Yang S, Cai Z, Zhang S, Zhou L, Yang J, Liu T, Jin S, Cui J. Wang L, et al. Among authors: zhou l. Mol Cell. 2023 Jan 19;83(2):281-297.e10. doi: 10.1016/j.molcel.2022.12.002. Epub 2022 Dec 30. Mol Cell. 2023. PMID: 36586411 Free article.

2

Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study.

Lu J, Xu X, Huang Y, Li T, Ma C, Xu G, Yin H, Xu X, Ma Y, Wang L, Huang Z, Yan Y, Wang B, Xiao S, Zhou L, Li L, Zhang Y, Chen H, Zhang T, Yan J, Ding H, Yu Y, Kou C, Shen Z, Jiang L, Wang Z, Sun X, Xu Y, He Y, Guo W, Jiang L, Li S, Pan W, Wu Y, Li G, Jia F, Shi J, Shen Z, Zhang N. Lu J, et al. Among authors: zhou l. Lancet Psychiatry. 2021 Nov;8(11):981-990. doi: 10.1016/S2215-0366(21)00251-0. Epub 2021 Sep 21. Lancet Psychiatry. 2021. PMID: 34559991

3

Single-cell transcriptome profiling of the human endometrium of patients with recurrent implantation failure.

Lai ZZ, Wang Y, Zhou WJ, Liang Z, Shi JW, Yang HL, Xie F, Chen WD, Zhu R, Zhang C, Mei J, Zhao JY, Ye JF, Zhang T, Li MQ. Lai ZZ, et al. Among authors: liang z. Theranostics. 2022 Sep 6;12(15):6527-6547. doi: 10.7150/thno.74053. eCollection 2022. Theranostics. 2022. PMID: 36185612 Free PMC article.

4

Metabolic enzyme UAP1 mediates IRF3 pyrophosphorylation to facilitate innate immune response.

Yang S, Jin S, Xian H, Zhao Z, Wang L, Wu Y, Zhou L, Li M, Cui J. Yang S, et al. Among authors: zhou l. Mol Cell. 2023 Jan 19;83(2):298-313.e8. doi: 10.1016/j.molcel.2022.12.007. Epub 2023 Jan 4. Mol Cell. 2023. PMID: 36603579 Free article.

5

Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice.

Gao H, Zhou L, Zhong Y, Ding Z, Lin S, Hou X, Zhou X, Shao J, Yang F, Zou X, Cao H, Xiao G. Gao H, et al. Among authors: zhou l. Nat Commun. 2022 Feb 23;13(1):1025. doi: 10.1038/s41467-022-28692-z. Nat Commun. 2022. PMID: 35197460 Free PMC article.

6

Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8⁺ T cells.

Helm EY, Zelenka T, Cismasiu VB, Islam S, Silvane L, Zitti B, Holmes TD, Drashansky TT, Kwiatkowski AJ, Tao C, Dean J, Obermayer AN, Chen X, Keselowsky BG, Zhang W, Huo Z, Zhou L, Sheridan BS, Conejo-Garcia JR, Shaw TI, Bryceson YT, Avram D. Helm EY, et al. Among authors: zhou l. Sci Immunol. 2023 Apr 28;8(82):eabn0484. doi: 10.1126/sciimmunol.abn0484. Epub 2023 Apr 28. Sci Immunol. 2023. PMID: 37115913 Free PMC article.

7

Identification of shared gene signatures and molecular mechanisms between chronic kidney disease and ulcerative colitis.

Liang Z, Hu X, Lin R, Tang Z, Ye Z, Mao R, Chen W, Zhou Y. Liang Z, et al. Front Immunol. 2023 Feb 13;14:1078310. doi: 10.3389/fimmu.2023.1078310. eCollection 2023. Front Immunol. 2023. PMID: 36860851 Free PMC article.

8

Comparison of Efficacy of Acupuncture-Related Therapy in the Treatment of Rheumatoid Arthritis: A Network Meta-Analysis of Randomized Controlled Trials.

Wan R, Fan Y, Zhao A, Xing Y, Huang X, Zhou L, Wang Y. Wan R, et al. Among authors: zhou l. Front Immunol. 2022 Mar 7;13:829409. doi: 10.3389/fimmu.2022.829409. eCollection 2022. Front Immunol. 2022. PMID: 35320944 Free PMC article.

9

The role of pyroptosis in hepatocellular carcinoma.

Zou Z, Zhao M, Yang Y, Xie Y, Li Z, Zhou L, Shang R, Zhou P. Zou Z, et al. Among authors: zhou l. Cell Oncol (Dordr). 2023 Aug;46(4):811-823. doi: 10.1007/s13402-023-00787-9. Epub 2023 Mar 2. Cell Oncol (Dordr). 2023. PMID: 36864264 Review.

10

Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer.

Wang G, Huang Y, Zhou L, Yang H, Lin H, Zhou S, Tan Z, Qian J. Wang G, et al. Among authors: zhou l. Crit Rev Oncol Hematol. 2023 Nov 9:104197. doi: 10.1016/j.critrevonc.2023.104197. Online ahead of print. Crit Rev Oncol Hematol. 2023. PMID: 37951282 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

1,575 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

1,575 results

Results by year